The GPR133 receptor is expressed by osteoblasts, the cells that make bone. The study suggests that this receptor helps those cells sense two kinds of input: mechanical strain and signals relayed by ...

Dublin, OH / Syndication Cloud / March 15, 2026 / SPRY 365 The Postmenopausal Bone Loss Crisis Every year after ...

John “Gabe” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking GLP-1s would come in with significant tendon injuries from relatively minor ...

Hormone therapy for menopause is safer than doctors had previously thought, new research says. It may also bring unexpected ...

Treatment with GLP-1 RAs for T2D and obesity is associated with increased risk for osteoporosis, gout, and osteomalacia compared with nonuse.

Explore updates on potential GLP-1 uses and risks, including addiction treatment, bone injury concerns, and kidney disease effectiveness.

While massage guns are generally safe when used correctly, improper use or existing medical conditions can lead to side effects, ranging from mild discomfort to rare but serious injuries.

Women’s health is different from men’s health. Not only do biological differences mean pregnancy, lactation and menstruation are unique to women, but some medical conditions are more common in women, ...

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.